Pharma Grade Isosorbide Market Revenue was valued at USD 350 Million in 2024 and is estimated to reach USD 650 Million by 2033, growing at a CAGR of 8.5% from 2026 to 2033.
The European pharmaceutical industry has witnessed a notable shift towards sustainable and bio-based materials, with pharma grade isosorbide emerging as a key player. Isosorbide, a diol compound derived from renewable sources like glucose, has found extensive applications in various sectors, particularly pharmaceuticals and personal care. Its unique chemical structure offers excellent thermal stability, rigidity, and resistance to moisture and UV light, making it an ideal candidate for numerous applications.
In the pharmaceutical sector, isosorbide derivatives such as isosorbide mononitrate and isosorbide dinitrate are widely used in the treatment of cardiovascular diseases. These compounds enhance the solubility and bioavailability of active pharmaceutical ingredients (APIs), improving the efficacy of drug formulations. The rising prevalence of cardiovascular diseases globally has significantly driven the demand for these isosorbide derivatives, thereby propelling market growth. Moreover, ongoing research and development activities aimed at discovering new therapeutic applications of isosorbide are expected to create new growth opportunities in the coming years.
The personal care industry in Europe has also embraced isosorbide due to its excellent moisturizing and emollient properties. Isosorbide derivatives are increasingly used in skincare and cosmetic formulations, catering to the growing consumer preference for natural and bio-based ingredients. The increasing disposable income and changing lifestyle patterns in emerging economies are boosting the demand for premium personal care products, which in turn is propelling the demand for pharma grade isosorbide.
From a regional perspective, Europe stands out as a significant market for pharma grade isosorbide. The continent's strong emphasis on sustainability and environmental regulations has led to a high demand for bio-based chemicals. Countries like Germany, France, and the UK have been at the forefront of adopting isosorbide in various applications. The European market is characterized by the presence of well-established pharmaceutical and personal care industries, further fueling the demand for isosorbide derivatives.
In terms of market dynamics, the increasing demand for sustainable and biodegradable materials is a primary growth driver. Isosorbide's renewable and biodegradable nature positions it as a greener alternative to petrochemical-based products. This shift towards eco-friendly materials is further supported by stringent environmental regulations and policies promoting the use of bio-based chemicals. However, challenges such as high production costs compared to conventional petroleum-based chemicals and limited awareness about isosorbide-based products may hinder market growth. Addressing these challenges requires concerted efforts in research and development to optimize production processes and enhance the availability of isosorbide-based products.
The competitive landscape of the European pharma grade isosorbide market is marked by the presence of several key players. Companies like Roquette Frères, SK Chemicals, and Mitsubishi Chemical Corporation are actively involved in the production and distribution of isosorbide derivatives. These companies focus on research and development, strategic collaborations, and product innovations to gain a competitive edge and expand their market presence. For instance, Roquette Frères has launched a new industrial unit for the production of isosorbide at its site in Lestrem, France, underscoring its commitment to meeting the growing demand for bio-based materials in Europe.
Looking ahead, the European pharma grade isosorbide market is poised for significant growth. The increasing adoption of sustainable materials, coupled with advancements in pharmaceutical formulations and personal care products, presents lucrative opportunities for market expansion. However, continuous efforts are needed to overcome production challenges and raise awareness about the benefits of isosorbide-based products. As industries strive to meet consumer demand for eco-friendly and effective products, pharma grade isosorbide is set to play a pivotal role in shaping the future of these sectors in Europe.
Get an In-Depth Research Analysis of the Europe Pharma Grade Isosorbide Market Size And Forecast [2025-2032]
Roquette
SK Holdings
Ecogreen Oleochemicals
ADM
Novaphene
Yu Teng
Hongbaifeng
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Europe region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Pharma Grade Isosorbide Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Pharma Grade Isosorbide Market
Pharmaceuticals
Food and Beverage
Cosmetics
Packaging Materials
Tablet Formulations
Liquid Formulations
Capsule Formulations
Powder Formulations
Pharma Grade
Food Grade
Industrial Grade
Synthetic Isosorbide
Natural Isosorbide
Pharmaceutical Industry
Food Industry
Cosmetic Industry
Packaging Industry
Biotechnology
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
For More Information or Query, Visit @ Pharma Grade Isosorbide Market Research Analysis
1. Introduction of the Europe Pharma Grade Isosorbide Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Market Size And Trends
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Pharma Grade Isosorbide Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Pharma Grade Isosorbide Market, By Type
6. Europe Pharma Grade Isosorbide Market, By Application
7. Europe Pharma Grade Isosorbide Market, By Geography
Europe
8. Europe Pharma Grade Isosorbide Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Market Size And Trends
Market Size And Trends is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.marketsizeandtrends.com/